· Centralized Procedure (CP)
· Mutual Recognition Procedure (MRP)
· Decentralized Procedure (DP)
Detail on each of these procedures is available here.
For marketing authorizations obtained through centralized procedure, Refer European Medicine Agency (EMA)’s website.
Important links for Centralized procedure:
|
EMA: Patient Information Leaflet (PIL), Summary of Product Characteristics (SPC) and European public assessment reports |
|
|
Union register of medicinal products (To check market exclusivity, orphan rug exclusivity, date of entry in register etc.) |
Link for Mutual Recognition and Decentralized procedure:
MRI Product Index (contains PIL, SPC and PAR of products approved through MRP or DP): Link
Links of individual countries of European Union:
|
COUNTRY |
LABEL (PIL) |
PUBLIC ASSESSMENT REPORT (PAR) |
COMMENT |
|
Austria |
|
|
|
|
Belgium |
|
|
|
|
Bulgaria |
|
|
|
|
Croatia |
|
|
|
|
Cyprus |
|
|
|
|
Czech Republic |
|
|
|
|
Denmark |
|
|
|
|
Estonia |
|
|
|
|
Finland |
|
|
|
|
France |
Public Assessment report (PAR) available only for the selected products |
||
|
Germany |
Public Assessment report (PAR) available only for the selected products |
||
|
Greece |
|
|
|
|
Hungary |
|
|
|
|
Iceland |
|
|
|
|
Ireland |
Public Assessment report (PAR) available only for the selected products |
||
|
Italy |
|
|
|
|
Latvia |
|
|
|
|
Lithuania |
|
|
|
|
Malta |
|
|
|
|
Netherlands |
Public Assessment report (PAR) available only for the selected products |
||
|
Norway |
|
|
|
|
Poland |
|
|
|
|
Portugal |
Public Assessment report (PAR) available only for the selected products |
||
|
Romania |
|
|
|
|
Slovakia |
|
|
|
|
Slovenia |
|
|
|
|
Spain |
|
|
|
|
Sweden |
Public Assessment report (PAR) available only for the selected products |
||
|
United Kingdom |
Public Assessment report (PAR) available only for the selected products |
No comments:
Post a Comment